FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

376136003: Pancrelipase, amylase:lipase 210.33mg capsule (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1458598012 Pancrelipase, amylase:lipase 210.33mg capsule (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1478428019 Pancrelipase, amylase:lipase 210.33mg capsule en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Pancrelipase, amylase:lipase 210.33mg capsule Is a Product containing pancrelipase (medicinal product) false Inferred relationship Some
    Pancrelipase, amylase:lipase 210.33mg capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. A substance containing enzymes, mainly lipase, with amylase and protease, obtained from the pancreas of the hog. It is a cream-coloured, amorphous powder having a faint characteristic, but not offensive odour. Its greatest activities are in neutral or faintly alkaline media; more than traces of mineral acids or large amounts of alkali hydroxides make it inert. An excess of alkali carbonate also inhibits its action. Pancrelipase contains, in each mg, not less than 24 USP units of lipase activity, not less than 100 USP units of amylase activity, and not less than 100 USP units of protease activity. false Inferred relationship Some
    Pancrelipase, amylase:lipase 210.33mg capsule Is a Product containing amylase and pancrelipase and triacylglycerol lipase (medicinal product) false Inferred relationship Some
    Pancrelipase, amylase:lipase 210.33mg capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Lipase false Inferred relationship Some
    Pancrelipase, amylase:lipase 210.33mg capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Amylase (substance) false Inferred relationship Some
    Pancrelipase, amylase:lipase 210.33mg capsule Has manufactured dose form A solid single-dose form that is a shell made of gelatin or other substances. The contents of the shell may be a solid, semi-solid or liquid. false Inferred relationship Some
    Pancrelipase, amylase:lipase 210.33mg capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Triacylglycerol lipase false Inferred relationship Some
    Pancrelipase, amylase:lipase 210.33mg capsule Is a TEMPORARY parent for CDs that are not updated false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    REPLACED BY association reference set (foundation metadata concept)

    Back to Start